Michael Wiederhorn
Stock Analyst at Oppenheimer
(0.44)
# 1919
Out of 5,240 analysts
124
Total ratings
48.67%
Success rate
5.19%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Centene | Maintains: Outperform | 95 85 | 63.44 | 33.98% | 12 | Dec 13, 2024 | |
UnitedHealth Group | Maintains: Outperform | 610 640 | 543.03 | 17.86% | 12 | Dec 6, 2024 | |
Pennant Gr | Maintains: Outperform | 34 37 | 26.49 | 39.68% | 6 | Nov 8, 2024 | |
HCA Healthcare | Maintains: Outperform | 390 400 | 305.87 | 30.77% | 10 | Oct 28, 2024 | |
Ensign Group | Maintains: Outperform | 165 168 | 133.46 | 25.88% | 7 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 400 280 | 282.58 | -0.91% | 12 | Oct 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 145 | 128.53 | 12.81% | 10 | Sep 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 40 | 13.71 | 191.76% | 3 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 21 17 | 9.35 | 81.82% | 10 | Aug 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 5 | 2.91 | 71.82% | 9 | Jul 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 370 400 | 284.87 | 40.41% | 6 | May 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Perform | n/a | n/a | n/a | 2 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 625 650 | 534.26 | 21.66% | 10 | Feb 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 145 | 92 | 57.61% | 7 | Oct 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 120 | n/a | n/a | 1 | Jul 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 146 | n/a | n/a | 4 | Aug 9, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 77 40 | n/a | n/a | 3 | Nov 2, 2017 |